TeselaGen Biotechnology Inc., the software company providing an all-in-one platform for seamless, scalable biotech R&D, announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes.
TeselaGen Biotechnology Inc., the software company providing an all-in-one platform for seamless, scalable biotech R&D, announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes.